David Bonita

Partner at OrbiMed Advisors LLC

David Bonita

David Bonita

Partner at OrbiMed Advisors LLC

Overview
RelSci Relationships

1525

Number of Boards

16

Birthday

1975

Age

44

Contact Data
Trying to get in touch with David Bonita? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals David Bonita likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman, President & Chief Executive Officer at Acutus Medical, Inc.

Relationship likelihood: Strong

Venture Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Co-Founder at Viewray Technologies, Inc.

Relationship likelihood: Strong

Founding General Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

General Partner & Co-Head of Global Private Equity at OrbiMed Advisors LLC

Relationship likelihood: Strong

Former President, Chief Executive Officer & Director at Viewray Technologies, Inc.

Relationship likelihood: Strong

Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Chief Executive Officer & President at Tricida, Inc.

Relationship likelihood: Strong

Founder at Clementia Pharmaceuticals Inc.

Relationship likelihood: Strong

General Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Paths to David Bonita
Potential Connections via
Relationship Science
You
David Bonita
Partner at OrbiMed Advisors LLC
Education
MBA, Alpha Omega Alpha Medical Honor Society & Beta Gamma Sigma Business Honor Society
Class of 2004

Columbia Business School (CBS) is the business school of Columbia University in Manhattan, New York City. It was established in 1916 to provide business training and professional preparation for undergraduate and graduate Columbia University students. It is one of six Ivy League business schools and its admission process is among the most selective of top business schools.

AB in Biological Sciences, magna cum laude

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Career History
Corporate Financial Analyst, Healthcare Investment Banking Group
Prior - 2003

Founded in 1998, UBS Securities LLC, formerly UBS Warburg LLC (U.S.), is an investment bank and registered broker/dealer located New York City. The firm is also a registered futures commission merchant. They are a subsidiary of UBS Americas, Inc. and their ultimate parent is UBS AG (NYSE: UBS). UBS Securities is a member of the NYSE, NASD, SIPC and FINRA.UBS Securities is a primary dealer in U.S. Government securities and provides a full range of investment banking services including corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. They offer closed-end fund research, commodity research, credit research, economic research, emerging market research, equity research, fixed-income research, foreign exchange research, real estate research, technical research and thematic research.

Private Equity Partner
2004 - Current

OrbiMed focuses exclusively on global investments across the entire spectrum of private and publicly-traded life sciences companies. They seek to invest in the most promising investment opportunities regardless of a company's stage of development. The firm invests at all stages of development from private start-ups and university spinouts to the largest global pharmaceutical companies. OrbiMed focuses on companies involved in drug development, drug discovery and medical devices, with particular emphasis on mid-stage private companies. Investments typically range from $5 million to $40 million. OrbiMed is generally a lead investor and takes an active role on their portfolio companies' boards of directors

Corporate Financial Analyst, Healthcare Investment Banking Group
1998 - 1999

Morgan Stanley provides investment banking products and services to its clients and customers including corporations, governments, financial institutions, and individuals. It operates through the following business segments: Institutional Securities, Wealth Management, and Investment Management. The Institutional Services segment provides financial advisory, capital-raising services, and related financing services on behalf of institutional investors. The Wealth Management segment offers brokerage and investment advisory services covering various types of investments, including equities, options, futures, foreign currencies, precious metals, fixed-income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs. The Investment Management segment provides equity, fixed income, alternative investments, real estate, and merchant banking strategies. The company was founded by Harold Stanley and Henry S. Morgan on September 16, 1935 and is headquartered in New York, NY.

Boards & Committees
Director
2018 - Current

Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm's lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland.

Member, Board of Directors
2014 - Current

Tricida, Inc. is a pharmaceutical company, which focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker in 2013 and is headquartered in South San Francisco, CA.

Chairman of the Board
2013 - Current

Clementia Pharmaceuticals, Inc. provides healthcare services. It is a biopharmaceutical company, which focuses on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease and involves in development and commercialization of treatments for people living with rare diseases. Clementia Pharmaceuticals was founded by Clarissa Desjardins and Jean-Claude Tardif on November 5, 2010 and is headquartered in Montreal, Canada.

Political Donations
$250
2008

Former President of United States

$200
2007

Former President of United States

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David Bonita. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David Bonita's profile does not indicate a business or promotional relationship of any kind between RelSci and David Bonita.